Bristol Myers Squibb Dividend Raise Streak is 18 Years. Here's 1 Number That Says the Streak Will Continue.
"Productivity initiatives" could prove key in maintaining this pharma company's decades-long dividend growth streak.
Overview
Among healthcare stocks, Bristol Myers Squibb (NYSE: BMY) has built a solid track record of dividend growth. The pharmaceutical company has increased its quarterly dividends during each of the past 18 years.
The company faces patent expirations for Eliquis and other flagship drugs, raising concerns that it can maintain (let alone grow) the dividend. Resolving the company's "patent cliff" remains a work in progress, but there is one important number that offers reassurances about this blue chip dividend stock's growth prospects.
Image source: Getty Images.
Details
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.